Jun 02, 2020
Citius Receives Positive FDA Feedback on Its Submitted Plan to Study Catheter Compatibility for Mino-Lok® Therapy
May 26, 2020
Citius Announces Expanded Access Program for Investigational Phase 3 Mino-Lok®
May 18, 2020
Citius Announces Closing of $7.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
May 13, 2020
Citius Announces Data on NoveCite Mesenchymal Stem Cells (NC-MSCs) to be Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
May 12, 2020
Citius Pharmaceuticals Issues May 2020 Shareholder Letter
Apr 27, 2020
Citius Announces Pre-IND Submission to FDA Under the Coronavirus Treatment Acceleration Program for a Novel Stem Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) in COVID-19
Apr 01, 2020
Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19
Mar 18, 2020
Citius Pharmaceuticals to Deliver Virtual Presentation at the Spring Investor Summit
Feb 26, 2020
Citius Pharmaceuticals to Present at the 2020 LD Micro Virtual Conference
Feb 25, 2020
Citius Pharmaceuticals Cites Independent Estimates of Total Available World Market for Mino-Lok®
Feb 10, 2020
Citius Pharmaceuticals to Present at Noble Capital Markets' 16th Annual Investor Conference
Feb 04, 2020
Citius Achieves 50% Patient Enrollment in Phase 3 Mino-Lok® Pivotal Trial
Dec 19, 2019
Citius Announces Positive Outcome of Interim Futility Analysis for its Phase 3 Mino-Lok® Pivotal Trial
Nov 08, 2019
Citius Pharmaceuticals Issues Corporate Update
Oct 24, 2019
Citius Pharmaceuticals to Present at the 5th Annual Dawson James Small Cap Growth Conference
Oct 15, 2019
Citius Pharmaceuticals to Present at the MicroCap Rodeo
Oct 07, 2019
Citius Reaches First Interim Analysis Milestone for Mino-Lok® Pivotal Trial
Oct 03, 2019
Citius Provides Update on Activities From IDWeek 2019
Sep 04, 2019
Citius Announces Change To Primary Endpoint In Mino-Lok® Phase 3 Study
Aug 29, 2019
Citius Pharmaceuticals, Inc. to Present at the RHK Capital 4th annual Disruptive Growth Conference hosted by Reed Smith.